DurgicalDurgical
EN
Open the app

Asthma !

Asthma is a long-term inflammation of the airways that makes them narrow in episodes, causing wheezing, breathlessness, chest tightness and cough.

Updated 2026-10-30

Structures involved

Tap one to see what it is and open it in 3D.

In biochemistry

In immunology

In histology

In the clinical exam

In physiology

Why it happens

What it is

Chronic inflammatory disease of the airways with variable, largely reversible airflow obstruction and hyperresponsiveness, causing recurrent wheeze, breathlessness, chest tightness and cough.

Who gets it

One of the most common chronic diseases in children and young adults; in Colombia and Latin America it is often under-diagnosed or under-treated, causing avoidable emergency visits. In ISAAC phase 3 (2002–2003), 11.8% of adolescents in three Colombian centres had current asthma, and a national study found 6.3% of Colombian adults with a medical diagnosis.

Causes

  • Allergic (atopic) airway inflammation, often type 2
  • Triggers: dust mites, animal dander, pollen, moulds
  • Viral respiratory infections
  • Exercise and cold air
  • Smoke, air pollution and occupational exposures
  • Aspirin or NSAID sensitivity in some patients

Risk factors

  • Personal or family history of atopy (eczema, allergic rhinitis)
  • Exposure to tobacco smoke, including in pregnancy
  • Obesity
  • Indoor and outdoor air pollution
  • Early-life viral infections
  • Occupational sensitisers

Pathophysiology

Airway inflammation with eosinophils, mast cells and Th2 cytokines makes bronchi hyperresponsive. Triggers cause smooth-muscle contraction, mucosal oedema and mucus plugging, which narrow the airway reversibly. Chronic disease can lead to airway remodelling with partly fixed obstruction.

Classification

  • By control: well controlled, partly controlled, uncontrolled
  • By severity: defined by the treatment step needed for control
  • Phenotypes: allergic, non-allergic, eosinophilic, exercise-induced, occupational

Symptoms and signs

  • Episodic wheeze
  • Shortness of breath
  • Chest tightness
  • Cough, often at night or early morning
  • Symptoms triggered by exercise, allergens, cold air or infections
  • Expiratory wheeze and prolonged expiration on examination

Diagnosis

Clinical
Typical variable symptoms with triggers; a history of atopy supports it. Examination may be normal between attacks.
Tests
Spirometry shows obstruction (reduced FEV1/FVC) with a significant bronchodilator response; peak-flow variability, bronchial challenge tests or FeNO help when spirometry is normal. Blood eosinophils and IgE for phenotype.
Imaging
Chest X-ray is usually normal; it is used to exclude other causes or complications such as pneumothorax.

Differential diagnosis

  • COPD
  • Vocal cord dysfunction
  • Heart failure (cardiac asthma)
  • Foreign body or airway tumour
  • Bronchiectasis
  • GERD-related cough

Goal of treatment

Achieve good symptom control, prevent exacerbations and loss of lung function, and minimise medication side effects with the lowest effective treatment step.

Treatment

Medical
Controller therapy: inhaled corticosteroids as the basis, with long-acting beta-2 agonists added at higher steps; leukotriene receptor antagonists as alternatives.
Medical
Reliever therapy: short-acting beta-2 agonists or a low-dose inhaled corticosteroid–formoterol combination as needed, per current guidelines; biologics for severe eosinophilic or allergic asthma.
Acute
Severe exacerbation: oxygen, repeated inhaled bronchodilators (beta-2 agonists plus antimuscarinics), systemic corticosteroids and, in selected cases, intravenous magnesium.
Lifestyle
Trigger avoidance, smoke-free environment, inhaler technique education and a written action plan.
Follow-up
Regular review of control, exacerbations and lung function to step treatment up or down.

Drugs for this condition

Complications

  • Life-threatening exacerbation and respiratory failure
  • Pneumothorax or pneumomediastinum
  • Airway remodelling with fixed obstruction
  • Side effects of repeated systemic corticosteroids

Prognosis

Most patients achieve good control with regular controller therapy and good inhaler technique. Childhood asthma often improves in adolescence; poor adherence and previous near-fatal attacks predict worse outcomes.

Prevention

  • Avoidance of tobacco smoke and known triggers
  • Influenza vaccination
  • Adherence to controller therapy to prevent exacerbations

Test yourself

Think of the answer, then tap the question to see it.

What spirometry finding supports a diagnosis of asthma?

Airflow obstruction (low FEV1/FVC) with a significant improvement in FEV1 after a bronchodilator, showing reversibility.

What is the cornerstone controller medication class in persistent asthma?

Inhaled corticosteroids, which reduce airway inflammation and the risk of exacerbations.

Why is a silent chest an ominous sign in an asthma attack?

It means airflow is so reduced that no wheeze is heard: a sign of life-threatening obstruction and impending respiratory failure.

How does asthma differ from COPD in its airflow obstruction?

In asthma obstruction is variable and largely reversible; in COPD it is persistent and not fully reversible after a bronchodilator.

Add to my cards (4)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: Asthma (StatPearls (NCBI Bookshelf), 2024); Asthma: epidemiology of disease control in Latin America - short review (Asthma research and practice, 2017) · adapted, CC BY 4.0.

← All conditions

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.

Segmental bronchi highlighted on the Durgical 3D model